We appreciate your interest in researching Lyme disease and other tick-borne infections. The application process to obtain research samples is as follows:


Initial contact

Prior to filling out and submitting forms, investigators interested in applying for research samples are strongly advised to contact Dr. Liz Horn at liz.horn@lymebiobank.org to discuss your project and sample needs.


The Biobank has two types of sample collections available, an unblinded panel of 15 samples and customizable panels of >500 blinded samples. The unblinded panel includes samples from 5 laboratory confirmed acute Lyme disease cases, 3 with convalescent draws, and 7 matched endemic controls. The unblinded panel includes all of the clinical data and testing data up front and is suitable for projects early in development, and previous testing in human samples is not required. The blinded samples are available for validation, and applications are submitted for peer review. All projects must have IRB approval or exemption, and a signed Sample and Data Use Agreement. Here are the two application forms with instructions for researchers:

Lyme Disease Biobank unblinded discovery panel

LDB Applicant Instructions Discovery Panel Instructions (PDF)
Application Form (.doc)

Lyme Disease Biobank sample access

LDB Applicant Instructions (PDF)
Application Form (.doc)

Forms should be submitted to Liz Horn, PhD, MBI, Principal Investigator at info@lymebiobank.org

Peer review

Applications for blinded samples undergo peer-review by an ad-hoc committee of at least two experts.

Final approval

Applications are presented to the Lyme Disease Biobank board for approval. Applicants will be notified by email when approved or declined.

Signed paperwork

De-identified samples are released upon receipt of an executed Sample and Data Use Agreement and approval or exemption from the applicant’s IRB.


For more information, please contact Liz Horn, PhD, MBI, Principal Investigator, at info@lymebiobank.org.


We would like to recognize and thank the Steven & Alexandra Cohen Foundation, the LaureL STEM Fund, and the 2018 Fund-a-Need supporters who have contributed significantly to our Lyme Disease Biobank.